SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-075519
Filing Date
2022-06-29
Accepted
2022-06-29 08:30:25
Documents
14
Period of Report
2022-06-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2219873d1_8k.htm   iXBRL 8-K 48235
2 EXHIBIT 3.1 tm2219873d1_ex3-1.htm EX-3.1 183364
  Complete submission text file 0001104659-22-075519.txt   554641

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abbv-20220623.xsd EX-101.SCH 5512
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20220623_def.xml EX-101.DEF 31848
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20220623_lab.xml EX-101.LAB 46738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20220623_pre.xml EX-101.PRE 29917
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2219873d1_8k_htm.xml XML 14641
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 221051887
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences